InsidersTradesSigma
Track the HEM파마 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HEM파마 has published 30 insider filings. Market capitalisation: €289.6bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 지요셉. All data is free.
28
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Fundamental score
Ranked 28,395 of 29,062 companies
10.7
score / 100
Value19
Quality3
FCF yld-6.5%
Earn yld-8.5%
EV/EBITDA·
ROE-194%
Gross mgn4.9%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations30 total
Other
Other
25 of 30 declarations
Acerca de HEM파마
HEM파마 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se especializa en el desarrollo y distribución de productos farmacéuticos.